Chemoinformaics analysis of 14-Methylpentadecanoic acid
| Molecular Weight | 256.43 | nRot | 13 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 15 |
| Exact Molecular Weight | 256.24 | nRing | 0 |
| Solubility: LogS | -3.924 | nHRing | 0 |
| Solubility: LogP | 2.9 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 49.6614 |
| nHD | 1 | BPOL | 32.9706 |
| QED | 0.431 |
| Synth | 4.03 |
| Natural Product Likeliness | 1.597 |
| NR-PPAR-gamma | 0.948 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.035 |
| Pgp-sub | 0.467 |
| HIA | 0.935 |
| CACO-2 | -4.975 |
| MDCK | 0.00000808 |
| BBB | 0.153 |
| PPB | 0.841109 |
| VDSS | 1.134 |
| FU | 0.171504 |
| CYP1A2-inh | 0.073 |
| CYP1A2-sub | 0.094 |
| CYP2c19-inh | 0.063 |
| CYP2c19-sub | 0.074 |
| CYP2c9-inh | 0.045 |
| CYP2c9-sub | 0.774 |
| CYP2d6-inh | 0.188 |
| CYP2d6-sub | 0.169 |
| CYP3a4-inh | 0.432 |
| CYP3a4-sub | 0.2 |
| CL | 9.927 |
| T12 | 0.305 |
| hERG | 0.011 |
| Ames | 0.337 |
| ROA | 0.221 |
| SkinSen | 0.2 |
| Carcinogencity | 0.274 |
| EI | 0.039 |
| Respiratory | 0.319 |
| NR-Aromatase | 0.045 |
| Antiviral | Yes |
| Prediction | 0.711942 |